CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 33 filers reported holding CATALYST BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,708 | +36.1% | 32,528 | 0.0% | 0.00% | – |
| Q2 2023 | $11,538 | +70.9% | 32,528 | 0.0% | 0.00% | – |
| Q1 2023 | $6,753 | -60.5% | 32,528 | 0.0% | 0.00% | – |
| Q4 2022 | $17,080 | +0.5% | 32,528 | 0.0% | 0.00% | – |
| Q3 2022 | $17,000 | -70.2% | 32,528 | 0.0% | 0.00% | – |
| Q2 2022 | $57,000 | +159.1% | 32,528 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | -26.7% | 32,528 | 0.0% | 0.00% | – |
| Q4 2021 | $30,000 | -77.6% | 32,528 | 0.0% | 0.00% | – |
| Q3 2021 | $134,000 | -5.0% | 32,528 | 0.0% | 0.00% | – |
| Q2 2021 | $141,000 | +1.4% | 32,528 | +18.5% | 0.00% | – |
| Q1 2021 | $139,000 | +0.7% | 27,443 | +23.0% | 0.00% | – |
| Q4 2020 | $138,000 | +42.3% | 22,320 | +2.6% | 0.00% | – |
| Q3 2020 | $97,000 | +47.0% | 21,747 | +93.6% | 0.00% | – |
| Q2 2020 | $66,000 | – | 11,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Colorado Capital Management, Inc. | 34,165 | $12 | 0.01% |
| JOHNSON & JOHNSON | 66,951 | $23,540 | 0.01% |
| Kynam Capital Management, LP | 89,886 | $31,604 | 0.00% |
| Nantahala Capital Management | 67,800 | $23,838 | 0.00% |
| Virtu Financial LLC | 48,633 | $17 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $7,032 | 0.00% |
| MORGAN STANLEY | 76,098 | $26,756 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 144,028 | $50 | 0.00% |
| BlackRock Inc. | 153,657 | $54,026 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 55,043 | $19,353 | 0.00% |